American Journal of Ophthalmology
Volume 140, Issue 2 , Pages 193.e1-193.e9 , August 2005

Whole Body Positron Emission Tomography/Computed Tomography Staging of Metastatic Choroidal Melanoma

  • Madhavi Kurli, MD

      Affiliations

    • The New York Eye Cancer Center, New York
    • The New York Eye and Ear Infirmary, New York
    • ,
  • Shantan Reddy, MD

      Affiliations

    • New York University School of Medicine, New York
    • ,
  • Lawrence B. Tena, MD

      Affiliations

    • The New York Eye Cancer Center, New York
    • The Saint Vincent’s Comprehensive Cancer Center, New York
    • The New York Eye and Ear Infirmary, New York
    • New York Medical College, New York, New York.
    • ,
  • Anna C. Pavlick, DO

      Affiliations

    • New York University School of Medicine, New York
    • ,
  • Paul T. Finger, MD

      Affiliations

    • The New York Eye Cancer Center, New York
    • The Saint Vincent’s Comprehensive Cancer Center, New York
    • The New York Eye and Ear Infirmary, New York
    • New York University School of Medicine, New York
    • Corresponding Author InformationInquiries to Paul T. Finger, MD, The New York Eye Cancer Center, 115 East 61st Street, New York, NY 10021; fax: 212-888-4030

,Accepted 23 February 2005.

References 

  1. Zimmerman LE . Metastatic disease from uveal melanomas. A review of current concepts with comments concerning future research and prevention . Trans Ophthalmol Soc UK . 1980;100:34–54
  2. Folberg R . Tumor progression in ocular melanoma . J Invest Dermatol . 1993;100:326–331
  3. Einhorn LH , Burgess MA , Gottlieb JA . Metastatic patterns of choroidal melanoma . Cancer . 1974;34:1001–1004
  4. Albert DM , Ryan LM , Borden EC . Metastatic ocular and cutaneous melanoma (a comparison of patient characteristics and prognosis) . Arch Ophthalmol . 1996;114:107–108
  5. Gragoudas ES , Egan KM , Seddon JM , et al.   Survival of patients with metastases from uveal melanoma . Ophthalmology . 1991;98:383–390
  6. Kath R , Hayungs J , Bornfeld N , Sauerwein W , Hoffken K , Seeber S . Prognosis and treatment of disseminated uveal melanoma . Cancer . 1993;72:2219–2223
  7. Char DH . Metastatic choroidal melanoma . Am J Ophthalmol . 1978;86:76–80
  8. Flaherty LE , Unger JM , Liu PY , Mertens WC , Sondak VK . Metastatic melanoma from intraocular primary tumors (the Southwest Oncology Group experience in phase II advanced melanoma clinical trials) . Am J Clin Oncol . 1998;21:568–572
  9. Abramson DH , Servodidio CA . Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation . Arch Ophthalmol . 1997;114:751–756
  10. Midena E , de Belvis V , Dei Tos AP , Antonini C . Isolated brain metastases of malignant choroidal melanoma 27 years after enucleation . Arch Ophthalmol . 1999;117:1553–1556
  11. Gherardi G , Scherini P , Ambrosi S . Occult thyroid metastasis from untreated uveal melanoma . Arch Ophthalmol . 1985;103:689–691
  12. Ruiz RS , El-Harazi S , Albert DM , Bryar PJ . Cardiac metastasis of choroidal melanoma . Arch Ophthalmol . 1999;117:1558–1559
  13. Dithmar S , Diaz CE , Grossniklaus HE . Intraocular melanoma spread to regional lymph nodes (report of two cases) . Retina . 2000;20:76–79
  14. Collaborative Ocular Melanoma Study Group . COMS manual of procedures . Springfield, Va: National Technical Information Service; 1995; Accession No. PB95179693.
  15. Wilson MW , Czechonska G , Finger PT , et al.   Chemotherapy for eye cancer . Surv Ophthalmol . 2001;45:416–444
  16. Moshfeghi DM , Moshfeghi AA , Finger PT . Enucleation . Surv Ophthalmol . 2000;44:277–301
  17. Finger PT . Radiation therapy for choroidal melanoma . Surv Ophthalmol . 1997;42:215–232
  18. Gombos DS , Van Quill KR , Uusitalo M , O’Brien JM . Geographic disparities in diagnostic screening for metastatic uveal melanoma . Ophthalmology . 2004;111:2254–2258
  19. Schoder H , Larson SM , Yeung HWD . PET/computed tomography in oncology (integration into clinical management of lymphoma, melanoma and gastrointestinal malignancies) . J Nucl Med . 2004;45:72S–81S
  20. Cohade C , Osman M , Leal J , Wahl R . Direct comparison of 18 F-FDG PET and PET/CT in patients with colorectal carcinoma . J Nucl Med . 2003;44:1797–1803
  21. Lindholm P , Minn H , Leskinen-Kallio S , Bergman J , Ruotsalainen U , Joensuu H . Influence of the blood glucose concentration on FDG uptake in cancer (a PET study) . J Nucl Med . 1993;34:1–6
  22. Lardinois D , Weber W , Hany TF , et al.   Staging of non-small cell cancer with integrated positron emission tomography and computed tomography . J Med . 2003;348:2500–2507
  23. Gorres GW , Steinert HC , von Schulthess GK . PET and functional anatomic fusion imaging in lung and breast cancers . Cancer J . 2004;10:251–261
  24. Freudenberg LS , Antoch G , Jentzen W , et al.   Value of (124) I-PET/CT in staging of patients with differentiated thyroid cancer . Eur Radiol . 2004;14:2092–2098
  25. Zimmer LA , McCook B , Meltzer C , et al.   Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer . Otolaryngol Head Neck Surg . 2003;128:178–184
  26. Freudenberg LS , Antoch G , Schutt P , et al.   FDG-PET/CT in re-staging of patients with lymphoma . Eur J Nuc Med Mol Imaging . 2004;31:325–329
  27. Schoder H , Yeung HW , Gonen M , Kraus D , Larson SM . Head and neck cancer (clinical usefulness and accuracy of PET/CT image fusion) . Radiology . 2004;231:65–72
  28. Larson SM , Schoder H , Yeung HW . Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer . Cancer J . 2004;10:243–250
  29. Bar-Shalom R , Yevremov N , Guralnik L , et al.   Clinical performance of PET/CT in evaluation of cancer (additional value for diagnostic imaging and patient management) . J Nucl Med . 2003;44:1200–1209
  30. Keidar Z , Haim N , Guralnik L . PET/CT using 18F-FDG in suspected lung cancer recurrence (diagnostic value and impact on patient management) . J Nucl Med . 2004;45:1640–1646
  31. Ciemik IF , Dizendorf E , Baumert BG , et al.   Radiation treatment planning with an integrated positron emission tomography and computer tomography (PET/CT) (a feasibility study) . Int J Radiat Oncol Biol Phys . 2003;57:853–863
  32. Finger PT , Kurli M , Wesley P , et al.   Whole body PET/CT imaging for detection of metastatic choroidal melanoma . Br J Ophthalmol . 2004;88:1095–1097
  33. Freudenberg LS , Schueler AO , Beyer T , et al.   Whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma . Surv Ophthalmol . 2004;49:537–540
  34. Eskelin S , Pyrhonen S , Summanen P , Prause JU , Kivela T . Screening for metastatic malignant melanoma of the uvea revisited . Cancer . 1999;85:1151–1159
  35. Hicks C , Foss AJE , Hungerford JL . Predictive power of screening tests for metastasis in uveal melanoma . Eye . 1998;12:945–948
  36. Diener-West M, Reynolds SM, Agugliaro DJ, et al. Screening for metastasis from choroidal melanoma: The Collaborative Ocular Melanoma Study Group. Report 23. J Clin Oncol 22:2438–2444.
  37. Collaborative Ocular Melanoma Study Group . Assessment of metastatic disease at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS) . Arch Ophthalmol . 2001;119:670–676
  38. Nathan FE , Berd D , Sato T , et al.   BOLD + interferon in the treatment of metastatic uveal melanoma (first report of active systemic therapy) . J Exp Clin Cancer Res . 1997;16:201–208
  39. Leyvraz S , Spataro V , Bauer J , et al.   Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy . J Clin Oncol . 1997;15:2589–2595
  40. Feldman ED , Pingpank JF , Alexander HR . Regional treatment options for patients with ocular melanoma metastatic to the liver . Ann Surg Onc . 2004;11:290–297

 Supported by The Eye Care Foundation, Inc. and Research to Prevent Blindness, New York, New York.

PII: S0002-9394(05)00274-6

doi: 10.1016/j.ajo.2005.02.051

American Journal of Ophthalmology
Volume 140, Issue 2 , Pages 193.e1-193.e9 , August 2005

Article Tools

* Image Usage & Resolution